Abstract CN17
Background
Telehealth improves the quality of life and overall survival of cancer patients. Social deprivation might lead to unequal access to telehealth. The aim of this study was to evaluate how socially deprived outpatients treated for a solid cancer get a grip on a dedicated telemonitoring program.
Methods
Between February 2021 and June 2022, eligible outpatients with a solid cancer undergoing chemotherapy at the Mondor Teaching Hospital, France, were provided with the ONCO'NECT® telemonitoring tool. It includes a chat system and standardized 24 items questionnaires before/after each treatment administration based on the NCCI Patient-Reported Outcomes of the Common Terminology Criteria for Adverse Events (PRO-CTCAE®), triggering alerts when the threshold of clinical significance was reached. Patients with social deprivation were identified based on the EPICES (evaluation of precariousness and health inequalities in health examination centres) score and were enrolled in the Re’Connect program (lending of a tablet, caregivers, technical and peer-to-peer support). We collected the data on patients’ healthcare pathways retrospectively, and we performed semi-structured interviews to assess patients’ challenges related to ONCO'NECT®.
Results
We enrolled 22 patients: 15 females, 50% were aged > 70 years (interquartile range (IQR), 64-74), 14 had digestive cancer, 15 patients had metastases, 14 lived alone. Five and three patients completed > 75% and < 25% of questionnaires respectively, during a median treatment duration of 7,5 months (IQR, 4-14). The median number of triggered alerts was 5 per patient (IQR, 1-9,25). The underuse of ONCO'NECT® went beyond patients’ understanding of its interest and their technical competence and was related to borderline health literacy. The related patients’ emotional negative experience might explain such an underuse.
Conclusions
Socially deprived cancer outpatients perceived the relevance of a telehealth tool. Beyond technical issues, patients’ borderline health literacy and their negative emotional experience should be addressed to ensure equal access to telehealth.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
French Cancer National Institute: Grant number PRECA20-009.
Disclosure
All authors have declared no conflicts of interest. Cancer nursing: Health promotion, prevention and screening
Resources from the same session
CN49 - Nurse–patient sexual health communication in gynecological cancer follow-up: A qualitative study from nurses’ perspectives
Presenter: Anita Paulsen
Session: Poster session 25
Resources:
Abstract
CN50 - Patient-reported outcome measures and supportive care need assessment in patients in a slovenian tertiary oncology centre
Presenter: Majda Causevic
Session: Poster session 25
Resources:
Abstract
CN51 - Psychometric properties of the Turkish version of the nurse spiritual therapeutic scale for oncology patients and caregivers
Presenter: Remziye Semerci
Session: Poster session 25
Resources:
Abstract
CN52 - Role of translational oncology research nurse (TORN) in improving patients (pts) adherence to microbiome research projects
Presenter: Ariadna Garcia Rodriguez
Session: Poster session 25
Resources:
Abstract
CN53 - Sexual function in survivors of hematological malignancy and autologous hematopoietic stem cell transplantation
Presenter: Ioanna Tsatsou
Session: Poster session 25
Resources:
Abstract
CN54 - Sexual health in women with breast cancer undergoing hormonal treatment
Presenter: Cristina Tebar
Session: Poster session 25
Resources:
Abstract
CN55 - The impact of psychosocial support on the overall health of cancer patients in the COVID-19 era
Presenter: Gianluca Catania
Session: Poster session 25
Resources:
Abstract
CN56 - Well-being and healthcare concerns of patients with advanced renal cell carcinoma: The RCC PROMs international survey
Presenter: Grigorios Kotronoulas
Session: Poster session 25
Resources:
Abstract
CN57 - Patients, informal caregivers and healthcare professionals experience in adoptive cell therapies: An experience-based co-design study (EBCD-ACT)
Presenter: Canova Canova
Session: Poster session 25
Resources:
Abstract
CN64 - Assessment of depression among lung cancer patients with type 2 diabetes using centre for epidemiologic studies depression scale (CES-D)
Presenter: Maria Lavdaniti
Session: Poster session 25
Resources:
Abstract